Skip to main content
. 2008 Jun 1;31(6):809–816. doi: 10.1093/sleep/31.6.809

Figure 2.

Figure 2

Mean (± SEM) change in coronary blood flow (CBF) and mean arterial blood pressure (MAP) from baseline over the course of the apnea cycle, at baseline (•) and post treatment (○) with lipopolysaccharide (LPS). * P < 0.05 compared to baseline for each condition. No difference between pre-LPS and post-LPS (2-way repeated measures ANOVA).